Anna Lemańska-Perek

Author

Anna Lemańska-Perek

Wroclaw Medical University ORCID

Also Known As

Anna Lemańska-Perek

Publications

312

Citations

H-Index

Concepts

All Affiliations

Wroclaw Medical University University of Warsaw Warsaw University of Technology

About

Anna Lemańska-Perek is an author at Wroclaw Medical University specializing in medicine, pathology, and fibrosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	114
2	Cell Biology	3	3	52
3	Engineering	1	1	12
4	Biomedical Engineering	1	1	12
5	Cellular Physiology	1	1	12

Anna Lemańska-Perek

Publications

253

Citations

H-Index

Page 1

	Year	Citations
Analysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis Anna Lemańska-Perek, Dorota Krzyżanowska‐Gołąb, Małgorzata Pupek, Inflammation	2016	33
Molecular Status of Plasma Fibronectin as an Additional Biomarker for Assessment of Alzheimer’s Dementia Risk Anna Lemańska-Perek, Jerzy Leszek, Dorota Krzyżanowska‐Gołąb, Dementia and Geriatric Cognitive Disorders	2009	27
Alterations in molecular status of plasma fibronectin associated with aging of normal human individuals Anna Lemańska-Perek, Małgorzata Pupek, Bożena Polańska, Clinical Biochemistry FibrosisAgingAutoimmune DiseasePlasma FibronectinLongevity	2013	26
Citrulline, Intestinal Fatty Acid-Binding Protein and the Acute Gastrointestinal Injury Score as Predictors of Gastrointestinal Failure in Patients with Sepsis and Septic Shock Maciej Tyszko, Anna Lemańska-Perek, Jakub Śmiechowicz, Nutrients	2023	23
Potential plasma biomarkers of bladder canceridentified by proteomic analysis: A pilot study Anna Lemańska-Perek, Jolanta Lis-Kuberka, Adam Lepczyński, Advances in Clinical and Experimental Medicine	2018	22
Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients Maciej Tyszko, Małgorzata Lipińska-Gediga, Anna Lemańska-Perek, Pathogens Critical Care ManagementPrognostic MarkerCritical Care MedicineIntensive Care UnitAcute Care	2022	22
Fibronectin as a Marker of Disease Severity in Critically Ill COVID-19 Patients Anna Lemańska-Perek, Dorota Krzyżanowska‐Gołąb, Barbara Dragan, Cells Intensive Care UnitViral DiagnosticsDisease SeverityCovid-19 PandemicViral Pathogenesis	2022	18
Presence of high-molecular-weight forms and domain alterations of fibronectin in pleural effusion of patients with lung cancer Małgorzata Pupek, Dorota Krzyżanowska‐Gołąb, Tomasz Dyła, Clinical Biochemistry Tumor BiologyFibrosisMedicinePathologyCell-matrix Interaction	2009	14
Occurrence of soluble supra-molecular FN–fibrin complexes in the plasma of children with recurrent respiratory infection Anna Lemańska-Perek, Bożena Polańska, Dorota Krzyżanowska‐Gołąb, Annals of Clinical Biochemistry International Journal of Laboratory Medicine	2014	14
[Fibronectin as an active component of the extracellular matrix]. Dorota Krzyżanowska‐Gołąb, Anna Lemańska-Perek, Iwona Kątnik‐Prastowska PubMed EngineeringCell AdhesionCytoskeletonBiomedical EngineeringCellular Physiology	2007	12

Page 1